Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB80380 in Lamivudine-Refractory Chronic Hepatitis B
NCT00895596Phase 2Completed
- Sponsor
- LG Chem
- Start
- Mar 2004
- Primary completion
- Aug 2006
- Modality
- Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of besifovir dipivoxil maleate in Chronic Hepatitis B (CHB), sponsored by LG Chem. Started Mar 2004; status: completed.
02
Drugs
besifovir dipivoxil maleate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00895596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00895596.